Internal Medicine, Gastroenterology · Lafayette, LA
NPI
1023350816
Since 2013
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
6
Medicare group memberships
Hospitals
5
Hospital affiliations
439 Heymann Blvd
Lafayette, LA, 70503
Phone (337) 269-0963
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
2,503 services
Medicare patients, 2024
572
Average age 73
Drug cost, 2024
$2.2M
2,721 prescriptions
Company payments, 2025
$922
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John B Rhodes Jr. was code 88305 (surgical pathology examination), 176 times for 113 patients. In total John B Rhodes Jr. billed 2,503 services in 66 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 88305 Surgical Pathology Examination | Office | 176 | 113 | $23.63 | $4,158 |
| 99213 Office E&M - Established | Office | 127 | 106 | $58.80 | $7,467 |
| 99232 Hospital E&M - Subsequent | Facility | 119 | 80 | $58.39 | $6,948 |
| 99222 Hospital E&M - Initial | Facility | 106 | 106 | $96.13 | $10K |
| 43239 Upper GI Endoscopy | Facility | 92 | 90 | $77.93 | $7,170 |
| 88313 Surgical Pathology Examination | Office | 73 | 54 | $49.07 | $3,582 |
| 43235 Upper GI Endoscopy | Facility | 69 | 68 | $84.09 | $5,802 |
| 99203 Office E&M - New | Office | 68 | 68 | $80.17 | $5,452 |
| 45385 Colonoscopy - Lesion Removal | Facility | 66 | 66 | $192.75 | $13K |
| 88312 Surgical Pathology Examination | Office | 59 | 49 | $59.82 | $3,529 |
| 99214 Office E&M - Established | Office | 47 | 42 | $86.71 | $4,075 |
| 43450 Digestive/Gastrointestinal | Facility | 42 | 41 | $27.24 | $1,144 |
| 99204 Office E&M - New | Office | 37 | 37 | $114.01 | $4,218 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 32 | 32 | $170.23 | $5,447 |
| 45380 Lower GI Endoscopy - Other | Facility | 29 | 29 | $135.00 | $3,915 |
By year: 2022 $147K for 1,560 services; 2023 $135K for 1,759 services; 2024 $133K for 2,503 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 176 | 113 | $23.63 | $4,158 |
| 88313 Surgical Pathology Examination | 73 | 54 | $49.07 | $3,582 |
| 88312 Surgical Pathology Examination | 59 | 49 | $59.82 | $3,529 |
| 82947 Clinical Chemistry | 11 | 11 | $3.85 | $42.35 |
Medicare prescription drug claims, 2024
In 2024, the drug John B Rhodes Jr. prescribed most often to Medicare patients was Pantoprazole Sodium, with 817 prescriptions and refills. In total John B Rhodes Jr. wrote 2,721 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 817 | 1,463 | 225 | $9,725 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 166 | 166 | 163 | $11K |
| Famotidine Generic | 156 | 303 | 44 | $2,079 |
| Dicyclomine Hcl Generic | 151 | 169 | 48 | $1,669 |
| Linzess Linaclotide | 133 | 169 | 28 | $89K |
| Sucralfate Generic | 124 | 183 | 48 | $5,986 |
| Sandostatin Lar Depot Octreotide Acetate,mi-Spheres | 87 | 87 | 12 | $389K |
| Amitriptyline Hcl Generic | 83 | 117 | 17 | $823 |
| Esomeprazole Magnesium Generic | 81 | 116 | 18 | $3,250 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 72 | 72 | 72 | $12K |
| Omeprazole Generic | 68 | 134 | 16 | $1,232 |
| Mirtazapine Generic | 56 | 59 | Under 11 | $271 |
| Metoclopramide Hcl Generic | 53 | 53 | 13 | $189 |
| Ondansetron Odt Ondansetron | 41 | 41 | 12 | $437 |
| Alosetron Hcl Generic | 41 | 41 | Under 11 | $19K |
Brand drugs: 632 claims; generic drugs: 2,089 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John B Rhodes Jr. $922 ($922 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $440.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 25 | $440 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $93.36 |
| Gilead Sciences, Inc. GILD | 2 | $57.6 |
| Ardelyx, Inc. ARDX | 3 | $48.81 |
| Genzyme Corporation SNY | 2 | $45.01 |
| Celltrion USA Inc. 068270.KS | 2 | $41.02 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $39.77 |
| QOL Medical, LLC | 2 | $33.36 |
| Aimmune Therapeutics, Inc. | 1 | $16.91 |
| Lilly USA, LLC LLY | 1 | $16.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.